Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic Dermatitis
Clinical trial NCT05544591 · COMPLETED
Trial details
- NCT number
- NCT05544591
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-26
- Primary completion
- 2023-07-10
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.